HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Going ‘Beyond The Pill’ – Sanofi To Partner With Digital Health Start-ups In Europe

Executive Summary

Sanofi is looking to work with European start-ups to develop innovative consumer health solutions that go 'beyond the pill'. The French firm is partnering with Silicon Valley's Plug and Play to identify promising digital technologies in the allergy and nutrition spaces.

You may also be interested in...



Sanofi Personalizing IBS Treatment With Digital Therapy

Sanofi Consumer Healthcare has teamed up with digital health player Cara Care to offer an innovative treatment for IBS which goes beyond the pill and helps sufferers access personalized support for their illness.

Sanofi Strikes Deal To Develop Respiratory Health App

Sanofi Consumer Healthcare is working with digital health firm ResApp to develop a mobile application which consumers can use to diagnose and manage respiratory illnesses. Such a tool has the potential to support novel Rx-to-OTC switch applications in future. 

Sanofi Partners With Colombian Tech Firm Rappi To 'Transform' Healthcare In Latin America

Sanofi Consumer Healthcare is utilizing emerging digital technology to take a bigger slice of the Latin American OTC market. Through a partnership deal, e-commerce and delivery firm Rappi will promote and sell Sanofi's brands to consumers across seven Latin American markets. 

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS148467

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel